A groundbreaking shift in our drug policy has happened, as the regulators allow the availability of psilocybin fungi for therapeutic treatment. Before this, these substances were heavily restricted, but a growing body of studies suggests they could offer benefits for mental health issues like depression. This development represents a substantial st